29Jan
UK Life Sciences and Healthcare Newsletter: Life Sciences - What's new in France?
Foreign direct investment control in France in time of COVID
To lower the risk of opportunistic trading resulting from the pandemic, the French government temporarily tightened its control over investments in strategic public companies. On 29 April 2020, the Ministry of Finance announced tighter controls over foreign investments into French companies, to protect them against opportunistic takeovers as a result of the COVID-19 pandemic....
By:
Dechert LLP
Source Url: https://www.jdsupra.com/legalnews/uk-life-sciences-and-healthcare-3513453/
Related
The Graduate Management Admission Council or GMAC has sent a letter to governmental leaders calling ...
Read More >
As part of a multi-faceted deal, Google will become a validator node for Theta’s Mainnet 2.0. As pa...
Read More >
The EEOC has a treasure trove. Woo-hoo! The Equal Employment Opportunity Commission has just posted...
Read More >
In a market with soaring multiples, private equity buyers are increasingly on the hunt to mitigate h...
Read More >
The wait is over. Earlier today, June 18, 2019 (and earlier than the July 1, 2019 due date), the Dep...
Read More >
Thomas H. Lee Partners and Frazier Healthcare Partners have acquired Adare Pharmaceuticals from TPG ...
Read More >